Literature DB >> 16210603

Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).

Sheryl E Kirwan1, Deborah N Burshtyn.   

Abstract

Inhibitory killer cell Ig-like receptors (KIR) signal by recruitment of the tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1 to ITIM. In the present study, we show that, surprisingly, KIR lacking ITIM are able to signal and inhibit in the human NK cell line NK92, but not in mouse NK cells. Signaling by mutant KIR is weaker than the wild-type receptor, does not require the transmembrane or cytoplasmic tail of KIR, and is blocked by overexpression of a catalytically inactive Src homology region 2 domain-containing phosphatase-1 molecule. We also demonstrate that mutant KIR signaling is blocked by Abs, which disrupt the interaction between KIR and human leukocyte Ag-C or Abs, which block the interaction between Ig-like transcript 2 (ILT2) and the alpha3 domain of HLA class I molecules. Thus, although ILT2 expressed in NK92 is insufficient to signal in response to human leukocyte Ag-C alone, ILT2 can signal in a KIR-dependent manner revealing functional cooperation between receptors encoded by two distinct inhibitory receptor families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210603     DOI: 10.4049/jimmunol.175.8.5006

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

2.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

Authors:  Ye Li; Rafet Basar; Guohui Wang; Enli Liu; Judy S Moyes; Li Li; Lucila N Kerbauy; Nadima Uprety; Mohsen Fathi; Ali Rezvan; Pinaki P Banerjee; Luis Muniz-Feliciano; Tamara J Laskowski; Emily Ensley; May Daher; Mayra Shanley; Mayela Mendt; Sunil Acharya; Bin Liu; Alexander Biederstädt; Hind Rafei; Xingliang Guo; Luciana Melo Garcia; Paul Lin; Sonny Ang; David Marin; Ken Chen; Laura Bover; Richard E Champlin; Navin Varadarajan; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Nat Med       Date:  2022-09-29       Impact factor: 87.241

4.  Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells.

Authors:  Oren Hershkovitz; Alon Zilka; Ahuva Bar-Ilan; Shai Abutbul; Andrew Davidson; Michela Mazzon; Beate M Kümmerer; Alon Monsoengo; Michael Jacobs; Angel Porgador
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

5.  LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.

Authors:  Xiaodong Zheng; Yanyan Wang; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

6.  LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Authors:  Kang Yu; Chelsea L Davidson; Agnieszka Wójtowicz; Luiz Lisboa; Ting Wang; Adriana M Airo; Jean Villard; Jeremie Buratto; Tatyana Sandalova; Adnane Achour; Atul Humar; Katia Boggian; Alexia Cusini; Christian van Delden; Adrian Egli; Oriol Manuel; Nicolas Mueller; Pierre-Yves Bochud; Deborah N Burshtyn
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

7.  Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

Authors:  Kuldeep S Cheent; Khaleel M Jamil; Sorcha Cassidy; Mengya Liu; Berenice Mbiribindi; Arend Mulder; Frans H J Claas; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

8.  Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.

Authors:  Silke Heidenreich; Christine Zu Eulenburg; York Hildebrandt; Thomas Stübig; Heidi Sierich; Anita Badbaran; Thomas H Eiermann; Thomas M C Binder; Nicolaus Kröger
Journal:  Clin Dev Immunol       Date:  2012-07-10

9.  Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells.

Authors:  Nicholas L Li; Chelsea L Davidson; Atul Humar; Deborah N Burshtyn
Journal:  Front Immunol       Date:  2011-09-20       Impact factor: 7.561

Review 10.  Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.

Authors:  Xunlei Kang; Jaehyup Kim; Mi Deng; Samuel John; Heyu Chen; Guojin Wu; Hiep Phan; Cheng Cheng Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.